Onconic Therapeutics, Co., Ltd. announced that it has raised KRW 26 billion in a round of funding from new investors The Korea Development Bank, Aju IB Investment Co., Ltd., Dt&Investment Co.,Ltd. K2 Investment Partners LLC, and SL Investment on December 9, 2022. The transaction included participation from returning investors BNH Investment LLC, Stonebridge Ventures Inc., Premier Partners, LLC, and Daol Investment Co.,Ltd. The company has raised KRW 46 billion in funding till date.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4,685 KRW | +1.41% | +4.34% | -23.70% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
4,685 KRW | +1.41% | +4.34% | 61.78M | ||
2,645 KRW | -0.75% | +0.57% | 227M | ||
1st Jan change | Capi. | |
---|---|---|
-23.70% | 61.78M | |
+31.41% | 12.02B | |
+14.40% | 3.06B | |
+2.96% | 1.42B | |
-8.46% | 1.22B | |
+1.15% | 616M | |
-10.84% | 579M | |
+35.79% | 577M | |
-4.17% | 492M | |
+33.85% | 488M |
- Stock Market
- Equities
- A330730 Stock
- News Stonebridge Ventures Inc.
- Onconic Therapeutics, Co., Ltd. announced that it has received KRW 26 billion in funding from a group of investors